Shares of genedrive plc (LON:GDR – Get Free Report) passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 1.98 ($0.03) and traded as low as GBX 1.50 ($0.02). genedrive shares last traded at GBX 1.50 ($0.02), with a volume of 3,571,504 shares traded.
genedrive Trading Down 0.2 %
The company’s fifty day moving average is GBX 1.97 and its two-hundred day moving average is GBX 2.14. The company has a quick ratio of 5.52, a current ratio of 4.60 and a debt-to-equity ratio of 0.35. The stock has a market cap of £8.50 million, a price-to-earnings ratio of -0.42 and a beta of -0.04.
genedrive (LON:GDR – Get Free Report) last announced its quarterly earnings data on Thursday, March 27th. The company reported GBX (0.40) (($0.01)) earnings per share for the quarter. genedrive had a negative net margin of 1,412.18% and a negative return on equity of 191.22%. On average, research analysts predict that genedrive plc will post 209.9999867 EPS for the current fiscal year.
genedrive Company Profile
ggenedrive plc is a pharmacogenetic testing company developing and commercialising a low cost, rapid, versatile and simple to use point of need pharmacogenetic platform for the diagnosis of genetic variants. This helps clinicians to quickly access key genetic information that will aid them make the right choices over the right medicine or dosage to use for an effective treatment, particularly important in time-critical emergency care healthcare paradigms.
Recommended Stories
- Five stocks we like better than genedrive
- What is Insider Trading? What You Can Learn from Insider Trading
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for genedrive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for genedrive and related companies with MarketBeat.com's FREE daily email newsletter.